Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Bausch & Lomb: Firm's revenues expected to grow in mid-single digits in FY 2004 based on continued strong sales from contact lens, lens care, pharmaceuticals categories, CEO Frank Zarrella projects during Oct. 30 earnings call. For the third quarter ended Sept. 27, B&L records 7.5% increase in lens care sales to $131.2 mil. as the ReNu brand continued to post impressive gains. Overall third quarter sales rose 9% to $508.8 mil.; net earnings totaled $32.3 mil. versus $9.4 mil. last year...